-
Something wrong with this record ?
Differential diagnosis of the small renal masses: role of the apparent diffusion coefficient of the diffusion-weighted MRI
Y. Mytsyk, I. Dutka, B. Yuriy, I. Maksymovych, M. Caprnda, K. Gazdikova, L. Rodrigo, P. Kruzliak, P. Illjuk, AA. Farooqi,
Language English Country Netherlands
Document type Journal Article
NLK
ProQuest Central
from 1999-01-01 to 1 year ago
Medline Complete (EBSCOhost)
from 2011-03-01 to 1 year ago
Health & Medicine (ProQuest)
from 1999-01-01 to 1 year ago
- MeSH
- Kidney Diseases, Cystic diagnosis MeSH
- Diagnosis, Differential MeSH
- Diffusion Magnetic Resonance Imaging methods MeSH
- Adult MeSH
- Carcinoma, Renal Cell * diagnosis pathology surgery MeSH
- Organ Sparing Treatments methods MeSH
- Middle Aged MeSH
- Humans MeSH
- Kidney Neoplasms * diagnosis pathology surgery MeSH
- Nephrectomy methods MeSH
- Reproducibility of Results MeSH
- Aged MeSH
- Sensitivity and Specificity MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
INTRODUCTION: Renal cell carcinoma (RCC) accounts for approximately 3% of adult malignancies and more than 90% of neoplasms arising from the kidney. Uninformative percutaneous kidney biopsies vary from 10 to 23%. As a result, 7.5-33.6% of partial nephrectomies in patients with small renal masses (SRM) are performed on benign renal tumors. The aim of this study was to assess the feasibility of the apparent diffusion coefficient (ADC) of the diffusion-weighted imaging (DWI) of MRI, as RCC imaging biomarker for differentiation of SRM. METHOD: Adult patients (n = 158) with 170 SRM were enrolled into this study. The control group were healthy volunteers with normal clinical and radiologic findings (n = 15). All participants underwent MRI with DWI sequence included. RESULTS: Mean ADC values of solid RCC (1.65 ± 0.38 × 10-3 mm2/s) were lower than healthy renal parenchyma (2.47 ± 0.12 × 10-3 mm2/s, p < 0.05). There was no difference between mean ADC values of ccRCC, pRCC and chRCC (1.82 ± 0.22 × 10-3 vs 1.61 ± 0.07 × 10-3 vs 1.46 ± 0.09 × 10-3 mm2/s, respectively, p = ns). An inverse relationship between mean ADC values and Fuhrman grade of nuclear atypia of solid ccRCCs was observed: grade I-1.92 ± 0.11 × 10-3 mm2/s, grade II-1.84 ± 0.14 × 10-3 mm2/s, grade III-1.79 ± 0.10 × 10-3 mm2/s, grade IV-1.72 ± 0.06 × 10-3 mm2/s. This was significant (p < 0.05) only between tumors of I and IV grades. Significant difference (p < 0.05) between mean ADC values of solid RCCs, benign renal tumors and renal cysts was observed (1.65 ± 0.38 × 10-3 vs 2.23 ± 0.18 × 10-3 vs 3.15 ± 0.51 × 10-3 mm2/s, respectively). In addition, there was a significant difference (p < 0.05) in mean ADC values between benign cysts and cystic RCC (3.36 ± 0.35 × 10-3 vs 2.83 ± 0.21 × 10-3 mm2/s, respectively). CONCLUSION: ADC maps with b values of 0 and 800 s/mm2 can be used as an imaging biomarker, to differentiate benign SRM from malignant SRM. Using ADC value threshold of 1.75 × 10-3 mm2/s allows to differentiate solid RCC from solid benign kidney tumors with 91% sensitivity and 89% specificity; ADC value threshold of 2.96 × 10-3 mm2/s distinguishes cystic RCC from benign renal cysts with 90% sensitivity and 88% specificity. However, the possibility of differentiation between ccRCC histologic subtypes and grades, utilizing ADC values, is limited.
Department of Radiology Lviv National Medical University Lviv Ukraine
Department of Urology Lviv National Medical University Pekarska Str 69 Lviv Ukraine
Euroclinic Medical Center Lviv Ukraine
Faculty of Medicine Central University Hospital of Asturias University of Oviedo Oviedo Spain
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc18033475
- 003
- CZ-PrNML
- 005
- 20181016112943.0
- 007
- ta
- 008
- 181008s2018 ne f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s11255-017-1761-1 $2 doi
- 035 __
- $a (PubMed)29230706
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Mytsyk, Yulian $u Department of Urology, Lviv National Medical University, Pekarska Str. 69, Lviv, Ukraine. mytsyk.yulian@gmail.com.
- 245 10
- $a Differential diagnosis of the small renal masses: role of the apparent diffusion coefficient of the diffusion-weighted MRI / $c Y. Mytsyk, I. Dutka, B. Yuriy, I. Maksymovych, M. Caprnda, K. Gazdikova, L. Rodrigo, P. Kruzliak, P. Illjuk, AA. Farooqi,
- 520 9_
- $a INTRODUCTION: Renal cell carcinoma (RCC) accounts for approximately 3% of adult malignancies and more than 90% of neoplasms arising from the kidney. Uninformative percutaneous kidney biopsies vary from 10 to 23%. As a result, 7.5-33.6% of partial nephrectomies in patients with small renal masses (SRM) are performed on benign renal tumors. The aim of this study was to assess the feasibility of the apparent diffusion coefficient (ADC) of the diffusion-weighted imaging (DWI) of MRI, as RCC imaging biomarker for differentiation of SRM. METHOD: Adult patients (n = 158) with 170 SRM were enrolled into this study. The control group were healthy volunteers with normal clinical and radiologic findings (n = 15). All participants underwent MRI with DWI sequence included. RESULTS: Mean ADC values of solid RCC (1.65 ± 0.38 × 10-3 mm2/s) were lower than healthy renal parenchyma (2.47 ± 0.12 × 10-3 mm2/s, p < 0.05). There was no difference between mean ADC values of ccRCC, pRCC and chRCC (1.82 ± 0.22 × 10-3 vs 1.61 ± 0.07 × 10-3 vs 1.46 ± 0.09 × 10-3 mm2/s, respectively, p = ns). An inverse relationship between mean ADC values and Fuhrman grade of nuclear atypia of solid ccRCCs was observed: grade I-1.92 ± 0.11 × 10-3 mm2/s, grade II-1.84 ± 0.14 × 10-3 mm2/s, grade III-1.79 ± 0.10 × 10-3 mm2/s, grade IV-1.72 ± 0.06 × 10-3 mm2/s. This was significant (p < 0.05) only between tumors of I and IV grades. Significant difference (p < 0.05) between mean ADC values of solid RCCs, benign renal tumors and renal cysts was observed (1.65 ± 0.38 × 10-3 vs 2.23 ± 0.18 × 10-3 vs 3.15 ± 0.51 × 10-3 mm2/s, respectively). In addition, there was a significant difference (p < 0.05) in mean ADC values between benign cysts and cystic RCC (3.36 ± 0.35 × 10-3 vs 2.83 ± 0.21 × 10-3 mm2/s, respectively). CONCLUSION: ADC maps with b values of 0 and 800 s/mm2 can be used as an imaging biomarker, to differentiate benign SRM from malignant SRM. Using ADC value threshold of 1.75 × 10-3 mm2/s allows to differentiate solid RCC from solid benign kidney tumors with 91% sensitivity and 89% specificity; ADC value threshold of 2.96 × 10-3 mm2/s distinguishes cystic RCC from benign renal cysts with 90% sensitivity and 88% specificity. However, the possibility of differentiation between ccRCC histologic subtypes and grades, utilizing ADC values, is limited.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a senioři $7 D000368
- 650 12
- $a karcinom z renálních buněk $x diagnóza $x patologie $x chirurgie $7 D002292
- 650 _2
- $a diferenciální diagnóza $7 D003937
- 650 _2
- $a difuzní magnetická rezonance $x metody $7 D038524
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a cystická onemocnění ledvin $x diagnóza $7 D052177
- 650 12
- $a nádory ledvin $x diagnóza $x patologie $x chirurgie $7 D007680
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a nefrektomie $x metody $7 D009392
- 650 _2
- $a léčba šetřící orgány $x metody $7 D059351
- 650 _2
- $a reprodukovatelnost výsledků $7 D015203
- 650 _2
- $a senzitivita a specificita $7 D012680
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Dutka, Ihor $u Euroclinic Medical Center, Lviv, Ukraine.
- 700 1_
- $a Yuriy, Borys $u Department of Urology, Lviv National Medical University, Pekarska Str. 69, Lviv, Ukraine.
- 700 1_
- $a Maksymovych, Iryna $u Department of Radiology, Lviv National Medical University, Lviv, Ukraine.
- 700 1_
- $a Caprnda, Martin $u 1st Department of Internal Medicine, Faculty of Medicine, Comenius University and University Hospital, Bratislava, Slovak Republic.
- 700 1_
- $a Gazdikova, Katarina $u Department of Nutrition, Faculty of Nursing and Professional Health Studies, Slovak Medical University, Limbova 12, 833 03, Bratislava, Slovak Republic. katarina.gazdikova@szu.sk. Department of General Medicine, Faculty of Medicine, Slovak Medical University, Bratislava, Slovak Republic. katarina.gazdikova@szu.sk.
- 700 1_
- $a Rodrigo, Luis $u Faculty of Medicine, Central University Hospital of Asturias (HUCA), University of Oviedo, Oviedo, Spain.
- 700 1_
- $a Kruzliak, Peter $u 2nd Department of Surgery, Faculty of Medicine, St. Anne's University Hospital, Masaryk University, Brno, Czech Republic. kruzliakpeter@gmail.com. Department of Chemical Drugs, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences, Palackeho Tr. 1/1946, 612 42, Brno, Czech Republic. kruzliakpeter@gmail.com.
- 700 1_
- $a Illjuk, Polina $u Department of Radiology, Lviv National Medical University, Lviv, Ukraine.
- 700 1_
- $a Farooqi, Ammad Ahmad $u Laboratory for Translational Oncology and Personalized Medicine, Rashid Latif Medical College, Lahore, Pakistan.
- 773 0_
- $w MED00002396 $t International urology and nephrology $x 1573-2584 $g Roč. 50, č. 2 (2018), s. 197-204
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/29230706 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20181008 $b ABA008
- 991 __
- $a 20181016113440 $b ABA008
- 999 __
- $a ok $b bmc $g 1339469 $s 1030469
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2018 $b 50 $c 2 $d 197-204 $e 20171211 $i 1573-2584 $m International urology and nephrology $n Int Urol Nephrol $x MED00002396
- LZP __
- $a Pubmed-20181008